TITLE:
Safety and Tolerability Study of Drug to Treat Schizophrenia

CONDITION:
Schizophrenia

INTERVENTION:
Lurasidone 20 mg

SUMMARY:

      The purpose of this study is to evaluate the long-term safety of SM-13496 in patients with
      schizophrenia.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 65 Years
Criteria:

        Inclusion criteria:

          -  Successful completion of participation in protocol #D1050049

        Exclusion criteria:

          -  Substance abuse

          -  Prolactin level of 200ng/mL at baseline

          -  Pregnancy
      
